PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2025 Ateme annonce un chiffre d'affaires trimestriel de 18,4 M€ en hausse de +4% (+3% à données comparables) et confirme ses objectifs financiers. Notoriété confirmée au NAB Show 2025 Chiffre D'affaires Croissance Objectifs Financiers ATEME NAB Show
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago FIRST QUARTER 2025 REVENUES Ateme reports Q1 revenues of €18.4 million, up 4% (+3% like-for-like), recent NAB Show confirms outstanding reputation. Financial objectives confirmed Growth Financial Objectives ATEME NAB Show Q1 Revenues
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago Invibes : Calendrier financier 2025/2026 Invibes Advertising annonce son calendrier financier 2025/2026 avec les dates clés de publication des résultats trimestriels et annuels. Détails sur la stratégie publicitaire et technologique de la société Calendrier Financier Invibes Advertising Publicité Digitale Intelligence Artificielle Campagnes Publicitaires
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago Invibes : 2025/2026 financial agenda Invibes Advertising announces its financial agenda for 2025/2026, including key revenue and results dates. Utilizing proprietary technology for efficient and value-driven advertising solutions Invibes Advertising Financial Agenda Proprietary Technology Advertising Solutions Revenue Dates
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago CHIFFRE D'AFFAIRES 2024-2025 À 534,5 M EUR Le Groupe LDLC enregistre un chiffre d'affaires annuel de 534,5 M€ en 2024-2025, marquant une amélioration au 4ème trimestre grâce aux innovations technologiques Chiffre D'affaires Croissance Marché Groupe LDLC Innovations Technologiques
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago 2024/2025 REVENUES: EUR 534.5M LDLC Group reports Q4 2024/2025 consolidated revenues of €137.9m, returning to growth in BtoC segment driven by technological innovations. Strong fundamentals with growth potential Revenues Growth Potential BtoC LDLC Group Technological Innovations
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago CHIFFRE D'AFFAIRES DU 1er TRIMESTRE 2025 DE 95,2 M EUR (+1,1%) - TRÈS BONNE DYNAMIQUE DU VOLUME D'AFFAIRES DES MAGASINS EN PROPRE (+6,1%) Roche Bobois SA enregistre une croissance de +1,1% de son chiffre d'affaires au 1er trimestre 2025, tirée par une dynamique commerciale positive et des prises de commandes en hausse Chiffre D'affaires Croissance Prises De Commandes Roche Bobois Dynamique Commerciale
PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago Q1 2025 REVENUE OF EUR 95.2M (+1.1%) - STRONG MOMENTUM IN RETAIL SALES FROM DIRECTLY OPERATED STORES (+6.1%) Roche Bobois SA reports Q1 2025 revenue of €95.2M (+1.1%), with strong momentum in retail sales from directly operated stores (+6.1%) and a sharp increase in order backlog. Delivery delays in the US and France affected results Order Backlog Retail Sales Roche Bobois SA Delivery Delays Q1 2025 Revenue
REGULATED PRESS RELEASE published on 04/24/2025 at 17:45, 10 months 4 days ago Chiffre d’affaires T1 2025 Le chiffre d’affaires T1 2025 de 600 M€ du Manitou Group a baissé de 12 % par rapport à 2024. Les commandes de machines augmentent, confirmant une stabilité prévue pour 2025 Chiffre D'affaires Manitou Group Prévisions 2025 T1 2025 Commandes Machines
Published on 02/28/2026 at 10:00, 8 hours 9 minutes ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 15 hours 9 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 16 hours 9 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 17 hours 59 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 16:55, 1 hour 14 minutes ago CGTN: How China's path of democracy safeguards people's rights and interests
Published on 02/28/2026 at 11:12, 6 hours 57 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 02/27/2026 at 19:30, 22 hours 39 minutes ago EUROPLASMA: Modification des caractéristiques des tranches 22 et 23 d’OCABSA
Published on 02/27/2026 at 23:00, 19 hours 9 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 23:00, 19 hours 9 minutes ago Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 18:02, 1 day ago AXA: Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA